Medline Inc.
L10
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | 633.00M | 826.00M | 933.00M | 935.00M | 1.23B |
| Total Depreciation and Amortization | 768.00M | 761.00M | 753.00M | 748.00M | 986.00M |
| Total Amortization of Deferred Charges | 40.00M | 44.00M | 45.00M | 45.00M | 58.50M |
| Total Other Non-Cash Items | 278.00M | 192.00M | 188.00M | 216.00M | 259.50M |
| Change in Net Operating Assets | -442.00M | -276.00M | -674.00M | -613.00M | -641.50M |
| Cash from Operations | 1.28B | 1.55B | 1.25B | 1.33B | 1.89B |
| Capital Expenditure | -335.00M | -337.00M | -290.00M | -296.00M | -379.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 6.00M | 0.00 | -890.00M | -1.01B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | -1.00M | -2.00M |
| Cash from Investing | -335.00M | -331.00M | -290.00M | -1.19B | -1.39B |
| Total Debt Issued | 7.57B | 7.75B | 14.04B | 8.65B | 12.46B |
| Total Debt Repaid | -11.68B | -11.86B | -14.09B | -9.18B | -12.76B |
| Issuance of Common Stock | 7.05B | 7.05B | -- | -- | -- |
| Repurchase of Common Stock | -1.99B | -2.00B | -28.00M | -13.00M | -21.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -215.00M | -215.00M | -1.48B | -1.40B | -1.46B |
| Other Financing Activities | -13.00M | -- | -8.00M | -11.00M | -11.50M |
| Cash from Financing | 723.00M | 727.00M | -1.56B | -1.96B | -1.79B |
| Foreign Exchange rate Adjustments | -11.00M | 5.00M | 4.00M | 5.00M | 8.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.65B | 1.95B | -605.00M | -1.81B | -1.28B |